Get notified when a new update is published!
The extended role of lyophilized factor concentrates in the perspectives of perioperative-patient blood management (P-PBM)
Published: October 9, 2024
Abstract
Tae-Yop Kim explores the extended role of lyophilized factor concentrates in the perspectives of perioperative-patient blood management (P-PBM) Patient blood management (PBM) is a patient-centered, systematic, evidence-based approach to improve patient outcomes by managing a patient’s own blood through diagnosis and etiology-specific treatment of anemia and preserving the patient’s own blood by minimizing blood loss and bleeding while promoting patient safety and empowerment.1 The World Federation of Societies of Anesthesiologists (WFSA) focuses on Perioperative PBM (Perioperative-PBM), which manages a patient’s blood before, during, and after surgery. This concept also focuses on improving patient outcomes, enhancing the efficiency of costly resource utilization, and reducing the risks of allogeneic blood transfusions in perioperative settings. While wisely managing anemia and minimizing blood loss are the core pillars of WFSA’s Perioperative-PBM, the rapid restoration and optimization of patients’ coagulation profiles are essential for reducing perioperative blood loss, minimizing allogenic blood transfusion, and improving patient outcomes.